Nicole Livescu
Family · New York, NYNPI 1003457094
Payments from drug & device makers
Across 100 payments — averaging $28.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$301
- Johnson & Johnson$267
- AbbVie$199
- Grifols USA, LLC$196
- Biogen$191
- Sobi, Inc$170
- plus $1K from 32 others
What the payments were for
- Consulting fees$602%
- Food & beverage$2,76198%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $301 |
| Johnson & Johnson | 11 | $267 |
| AbbVie | 8 | $199 |
| Grifols USA, LLC | 4 | $196 |
| Biogen | 3 | $191 |
| Sobi, Inc | 7 | $170 |
| Merz North America, Inc. | 1 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $140 |
| Sanofi | 6 | $136 |
| Lundbeck LLC | 5 | $115 |
| Revance Therapeutics, Inc. | 1 | $84 |
| Puma Biotechnology, Inc. | 4 | $79 |
| Merck | 3 | $64 |
| Springworks Therapeutics, Inc. | 2 | $55 |
| Kyowa Kirin, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $46 |
| GSK | 2 | $45 |
| Novartis | 2 | $40 |
| Incyte Corporation | 2 | $38 |
| Amgen(2 entities) | 2 | $35 |
| Octapharma USA, Inc. | 1 | $33 |
| Recordati_rare_diseases_inc. | 1 | $31 |
| AstraZeneca | 1 | $29 |
| Pharmaessentia USA Corporation | 1 | $27 |
| Boehringer Ingelheim | 1 | $27 |
| Tersera Therapeutics LLC | 1 | $25 |
| Deciphera Pharmaceuticals Inc. | 1 | $25 |
| Taiho Oncology, Inc. | 1 | $24 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| Galderma Laboratories, L.p. | 1 | $23 |
| Eisai Inc. | 1 | $21 |
| Morphosys, US Inc. | 1 | $21 |
| GRT US Holding, Inc. | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $21 |
| Celltrion USA Inc. | 1 | $21 |
| Spectrum Pharmaceuticals Inc. | 1 | $20 |
| Servier Pharmaceuticals LLC | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Gamunex-C$125
- INJECTAFER$120
- TYSABRI$113
How this compares
$2,821 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.
Other family in New York
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Mary Sullivan-WhalenNew York$137K
- Leslie WoronaNew York$77K
- Thomas SaglimbeniNew York$48K
- Kathryn JohnsonNew York$48K
- Derek PinedaNew York$38K
- Rebecca SchoriNew York$32K
- Evangelia NezisNew York$22K
- Colette NelsonNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.